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A membrane receptor for insulin on cultured human ke-
ratinocyte monolayers has recently been reported. It has 
also been es tablished by previous investigators that the re-
ceptors for insulin and the somatomedin peptide, insulin-
like growth factor-l/somatomedin-C (IGF-I), have similar 
oligomeric composition. However, these 2 receptors can 
be distinguished by their high affinitiy for their respective 
peptides. The present study was undertaken to identify and 
characterize IGF-I receptors on human keratinocytes, using 
time courses at different temperatures , co mpetitive dis-
placem ent of ['2SI]IGF_I by unlabeled IGF-I and insulin, 
and comparative binding ofIGF-I, IGF-II , and insulin . The 
binding of[' 2s'I]JGF-1 was time and temperature dependent, 
achieving steady state after 6 h of incubation at 15°C. Spe-
cific binding at 15°C averaged 4.33 % for 0.8-1.0 million 
I nsulin-like growth factors (IGFs) constitute a family of growth hormone-dependent peptides with anaboli c and mitogenic properties in a variety of tissues and cell lines of both hum an and lower m ammalian origin (reviewed in [1 ,2]). Comple-m entary to these peptides, 2 distin ct m embrane recepto rs 
have been identified . The type-I receptor has a higher affinity for 
IGF-I than IGF-II, and insulin co mpetes onl y at high concentra-
tions [3]. The type-II receptor, on the other hand , has greater 
affinity for lGF-1l than for IGF-I, and insulin does not interact, 
even at high concentrations [3]. The IGFs and insulin, which are 
structurally related peptides, mediate their biologic action by binding 
tei these specifi c m embrane receptors. Affinity labeling and affin-
ity purifi cation techniques have es tablished that the recepto rs fo r 
insulin and lGF-1 have a similar oligomeric composition, with 2 
a subunits (Mr = 125,000) and 2 {3 subunits (M r = 90,000), linked 
in a heterotetram cric disulfide-linked co mplex [4,5] . 
The structurall y similar receptors for insulin and IGF-I can be 
easily distinguished by their relative affi nity for these 2 peptides. 
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cells. Competition for binding was observed at IGF-I COn-
centrations as low as 1 ng/ ml , with half maximal displace_ 
ment of [' 251]IGF_I at IGF-I concentration of 17 ng/ml. 
Insulin, on the other hand, was 100-fold less potent than 
IG F-I in displacing [125I]IGF-1. Scatchard analysis of the 
competitive binding data revealed a curvilinear piot, with 
a calculated Kd = 1.4 X 10 - 9 mollliter . When the binding 
of [12S I]IGF_I, -IGF-II, and -insulin was compared in the 
sa me experiment, the specific binding of [' 2sJ]I GF_I was 
3.43% as compared with 5.60% for [' 2S I]insulin and 0.90% 
for ['2SI]I GF_Il. The findin g of specific IGF-I receptors On 
cultured hum an keratinocytes sugg'es ts a possible role for 
this mitogenic peptide in epidermal cell proliferation. ) 
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Human keratinocytes, as shown by previo us in vestiga tors, have 
receptors fo r in sulili and epiderm al g rowth factor [6-8]. In this 
stud y, we characterize th e binding of IGF-I to hum an keratino _ 
cytes and compare it w ith the bindin g of insulin and IG F-IL 
MATEn.IALS AND METHODS 
Cells Human keratin ocy te mo no layers were prepared acco rding 
to previously published m ethods [9]. Normal fu ll-thickness hu-
man skin was obtained at surgery and cut into 1 X 5 cm s trips. 
These strips were further split-cut with a Castroviejo keratome 
(Storz Instrum ent Co., St. Louis, Misso uri) set at 0.1 mm. Strips 
of split- thickness skin were then trea ted for 25 min at 37C with 
0.3% trypsin in 0.8% N aCI, 0.04% KCl , 0.1 % glu cose, 0 .084% 
NaHC03, and 0. 1 % EDTA (pH 7.3). The skin slices were washed 
transferred to Dulbecco's modified Eagle's medium (Gibco, Grand 
Island , N ew York), plus 10% hea t-inac tivated fetal ca lf serum 
50 JLg/ ml gentamicin ,2 mM L- glu tamine (complete m edium), and 
th e keratinocytes were released into the medium by gentle agi-
tation . For culture of epidermal cell s, 2 x 10c, viable, ro und 
refractile cells o btained from the no rmal skin , were plated on ~ 
collagen thin gel-coated 3 .5-cm Lux Petri dish (Flow Labora to_ 
ries, In g lewood, Cali fornia) and incubated in 5% CO2:95% air 
at 37°C. C ulture m edium was not supplemented with epidermal 
growth factor o r g lucocorticoids. Vi ability before culture, deter-
mined by trypan blue exclusion , was generally over 80- 90%. 
M onolayer cultures were devoid of fibroblas ts by m o rphologic 
criter ia (Fig 1) as well as by immunofluorescent sta ining with 
rabbit antivimentin and antikeratin antibodies; a flu o rescein-con-
juga ted goa t antirabbit immunoglobulin was employed as the I 
second-stage antibody in these experiments. Usin g human fibro-
blast mo nolayers as a control, hum an keratinocytes did no t dem-
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Figure 1. Li ght micrograph of keratinocytc culture after 7 days of plat-
ing. showing monob yer of typica l epithelial morphology. 
onstrate any Auorescein stainin g whcn antivimcntin antibody was 
used . Antikeratin antibody, on the other hand , stained > 95% 
cells . 
Pep tides Insulin-like growth factor- I1somatomedin-C was pu-
rified by a modifi ca tion of our previously published methods [10] . 
The acid-ethanol extract of human Cohn fraction IV-paste was 
chromatographed on a Sephadex G-50 in 0.05 M formi c acid as 
a solvent. The active fracti ons were pooled , lyophilized , and chro-
matographed on a Sephadcx G-50 column in 0.05 M NaHC03. 
After lyophi liza tion, the fractions were further purifi ed by thin-
layer isoelectric focusing, fo llowed by Sephadex G-50 chroma-
tography in 0.05 M NaH COJ to remove th e ampholytes. The 
IGF-ll w as a genero us g ift o f Dr. Kerstin H all (Stockholm , Swe-
d en) . Porcine insulin was purchased from E li Lilly Co. (Indian-
apolis, Indi ana). [1251]Peptide was prepared by a modifi ca tion of 
the method of Hunter and Grcenwood [11] to a specifi c activity 
of 100-250 JJ-Ci /JJ-g. Subsequcntl y, iodinated peptide was chro-
m atographed by cellulose chromatog raph y. Before use in binding 
assays, the iodinated peptide was repurified by gel filtration on a 
Sephadex G-50 column (1 X 120 cm). 
Binding Assay Human keratinocytes were grown to con-
fluency in 35-mm plastic dishes . All experiments w ere performcd 
3-5 days after the last feeding with complete m edium . Just prior 
to binding assays, culture m edium was aspirated and monolayers 
were washed twice with HEPES buffer (100 mM HEPES, 120 
mM NaCl , 1.2 mM MgS04 , 5 mM KCI , and 10 mM dextrose) 
with 1 % bovine serum albumin (BSA), pH 7.4. Monolayers were 
then incubated w ith [125 IJI G F_I o r other rad ioli gand (50,000 cpm 
total) plus increasing concentrations of unlabeled peptide, in a 
fina l vol ume of 1 ml HEPES buffer with 1 % BSA, pH 7.4. 
Incubations were performed at 15°C, 37°C, or 4°C for various 
times. At co mpletion of incubation the binding buffcr was as-
pirated, and monoiayers were washed 3 tilTlcS w ith icc-cold phos-
phate-buffered sa line, with 1 % BSA, pH 7.4. Keratinocyte mono-
layers were then solubilized in 1 m11 % sodium dodecyl sulphatc 
(SDS) and the dissolved cells were transferred to polypropylene 
tubes. Plates were subsequently rinsed with an additional 1 1111 of 
1 % SDS; this, too, w as transferred to the polypropylene tubes. 
Duplicate 500-JJ-l aliquots of this fin al 2-1111 vo lume were counted 
in a ')I-counter for determination of cell-bo und radioactivity. Non-
specific binding was defi ned as the percentage of radioactivity 
remaining bound in the presence of excess unlabeled peptide (con-
centrations used were: IGF-l 550 ng/ml, IGF- II 500 ng/ml , and 
insulin 10 JJ- g/ ml). Because of the shortage of pure peptides, a 
pa rti all y pure preparation ofIGFs was employed to determine the 
nonspecific binding [1 2] . Cell number, determined in duplicate 
pla tes by Coulter Counter and confirmed by hemocytometer, 
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averaged 0.8-1.0 million cells per plate. Receptor number and 
affinity were determined by Scatchard ana lysis [13), as modified 
by Kahn ct al [14]. 
RESULTS 
Effect of Time and Temperature on Binding As depicted 
in Fig 2, the specific binding of [125IJIGF_I was tim e and tem-
perature dependent. At 15°C (Fig 2A), a steady state condition 
was dem onstrable after approximately 6 h of incubation , and the 
specific binding averaged 4.33%. Addition of unlabeled peptide, 
after 2 h of incubation of 1110nolayers with radioligand, resulted 
in mo re th an 50% dissociatio n of the radioligand. The nonspecific 
binding was 1 % of the tota l counts added and showed minimal 
change between 2 and 20 h. T he time course o f[ 125IJI G F-I binding 
at 4°C demonstrated gencrall y lower binding, and steady state 
was not achieved, even after 20 h of incubation . The specific 
binding of [125IJIGF_I to human keratin ocytes was considerably 
less at 37°C (Fig 2B), peaking at 2 h, followed by a gradual de-
crease over thc ncxt 5 h of incubation. The binding of[ 125IJIGF-1 
was stable over a wide ran ge of pH (pH 6.0- 8.5) . Subsequently 
all ex periments were perfo rm ed at pH 7.4, with an incubation 
time of 6 h at 15°C. The trichloroacetic acid precipitability of the 
peptide was > 95% after 6 h of incubation at 15°C. 
Specificity of the Receptor Fig 3 dcmonstrates the displace-
ment of [125 IJI GF-I from human keratinocytes by unlabeled IGF-
I and insulin. IGF-I demonstrated a high affinity, with 50% dis-
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Figure 2. Binding of I !2SI JIGF-I to hUlllan keratinocytes plotted as a 
function of duration of incubation. At indicated temperature, monob yers 
(0.8-1.0 million cells/plate) were incubated with J I 25IJI GF-I in the presence 
or absence of unlabeled IGF-I (550 ng/ml). Specific binding was deter-
mined by subtracting nonspecific binding from the tota l binding. Each 
point represen ts average of duplicate determinations, SE < 1 0% . A, Time 
course at 15°C; 8, time course at 4°C and 3rc. 
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Figure 3. Competitive inhibition of binding of r25I]IGF-I to human 
keratinocytes. Monolayers were incubated for 6 h at 15°C with.[125I]IGF-
I in the absence and presence of indicated concentrations of unlabeled 
IGF-I (opw circle) and insulin (solid circle) . Nonspecific binding for [125I]IGF_ 
I was defined as the binding observed in the presence of 550 ng/ml of 
IGF-I and has been subtracted from the total binding. Data are expressed 
as a percent of the maximal specific binding (3.34% per approximate 1.0 
million cells). Each point represents the average of duplicate determina-
tions. SE < 10%. 
placement of [1251]IGF_I at concentrations of 17 ng/ml (2.3 X 
10- 9 moilliter) . .Insulin was approximately 100-fold less potent 
than IGF-I, with 50% displacement observed at 1 J.Lg/ml (2 x 
10- 7 mol/ liter) of unlabeled insulin. When the competitive bind-
ing data for IGF-I were subjected to Scatchard analysis [13,14] a 
curvilinear plot was observed, suggesting either 2 binding sites 
oflow and high affinity, or negative cooperativity (Fig . 4) . Anal-
ysis of the high-affinity component showed a Kd of 1.4 x 10- 9 
mol/liter, with approximately 28,000 high-affinity receptors per 
cell. 
Comparison of P2SI]IGF_I, P2SI]IGF-II, and p2SI]Insulin 
Binding to Human Keratinocytes Fig 5 compares the specific 
binding of IGF-I, IGF-II, and insulin with keratinocyte mono-
layers . Specific binding of [I251]insulin was highest, averaging 
5.6% per 106 cells. Specific binding of[125I]IGF-1 averaged 3.43% 
per 106 cells, while binding of [125I]IGF_1I was only 0.90% per 
106 cells. 
DISCUSSION 
Insulin-like growth f.'lctors (somatomedins) constitute a family of 
growth hormone-dependent pep tides with anabolic and mito-
genic activity for a variety of cell lines [1,2]. So far, 2 human 
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Figure 4. Scatchard analysis of the data from Fig 3. 
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Figure 5. Comparison of specific binding of[l25I]insulin, [1251]IGF_I, and 
[125I]IGF-II to human keratinocyte monolayers . Monolayers (0.8-1.0 mil-
lion cells/plate) were incubated for 6 h at 15°C with the radioligand. 
Nonspecific binding for [1251]IGF_I and [125I]IGF-II was defined as the 
binding observed in the presence of 550 ng/ml of IGF-I and 500 ng/ml 
of IGF-II, respectively, and has been subtracted from the total binding. 
Nonspecific binding of [125I]insulin was defined as the counts bound in 
the presence ofl0 JLg/ml of insulin and has been subtracted from the total 
binding. Data are expressed as percent specific binding ± SD (bars) per 
1.0 million cells for each radioligand. 
somatomedins, IGF-I and -II, have been isolated and sequenced 
[15,16]. With the development of radioimmunoassays for these 
peptides, a strong dependency of serum IGF-I on serum growth 
hormone levels, has been demonstrated. Thus, children with growth 
hormone deficiency are known to have low serum IGF-I levels 
while patients with acromegaly have high IGF-I levels . Further_ 
more, IGF-I demonstrates potent mitogenic action on a variety 
of cell lines, presumably mediated through specific membrane 
receptors. 
Human keratinocytes, as established by other investigators [7,8], 
have high-affinity receptors for epidermal growth factor (Kd = 
2 X 10- 10 mol/liter) and insulin (Kd = 0.45 X 10- 9 mOl/liter). 
Furthermore, previous work has also shown that human Cohn 
fraction IV , which is known to contain IGF-l and IGF-II , has a 
stimulatory effect on human keratinocyte cultures [17]. To OUr 
knowledge, binding sites for IGF-I have not been studied in this 
cell type. However, in human fibroblasts, as demonstrated by us 
and other investigators, IGF-I has specific binding sites and is 
capable of stimulating thymidine incorporation and cell replica-
tion [3,10,18]. 
In the present study we have characterized the IGF-I receptors 
on cultured human keratinocytes. The binding of [125l)IGF_I was 
time and temperature dependent, with steady state observed after 
6 h of incubation at 15°C. T he competition for IGF-I radioligand 
was observed at IGF-I concentration as low as 1 ng/ml, with half 
maximal displacement at a concentration of 17 ng/ml. Insulin, 
on the other hand, was approximately 100-fold less potent in 
displacing IGF-I radioligand. Thus, [1 25IJIGF-I appears to be bind-
ing to a classical type-I receptor, with a calculated Kd of 1.4 X 
10- 9 mol / liter. When the binding of 3 related peptides, insulin, 
IGF-I, and IGF-II, were compared simultaneously in human ke-
ratinocytes, an interesting pattern was seen. [125l]lnsulin showed 
the maximal binding and, surprisingly, [125IJIGF-Il binding was 
the least. This pattern of relative binding is quite different from 
what has been reported for human fibroblasts: [125IJIGF_1I > 
[125I]IGF_I > [I251]insulin [19] . 
Our finding of specific IGF-I receptors on human keratinocytes 
suggests a potential role for this peptide in epidermal growth. It 
is interesting to speculate that human skin fibroblasts , which con-
VOL. 87. NO.2 AUGUST 1986 
stitute the majority of th e cells of the dermis compartm ent and 
have been shown to produce an IGF-l-Iike peptide in culture [20], 
m ay contribute to the proximal stimuli which control stem cell 
proliferation and maintain normal epidermal growth . Further-
more, clinical studies by other inves ti gato rs have suggested higher 
growth hormone levels in patients w ith psorias is, as compared 
w ith control subj ects [21] . Although results from other studies 
have not always been consistent with this fllldin g [22], the pres-
ence of specific IGF-I receptors on human keratinocytes and the 
k nown dependency of IGF-I on serum growth horm one sugges ts 
a mechanism whereby growth hormone may have an indirect 
role in normal and disordered epidermal growth . In spite of this 
interestin g speculation, the relative importance of these pep-
tides-IGF-I , insulin , and IGF-ll-in the regulation of epiderm al 
cell proliferation remains unclear. Studies designed to evaluate 
the bio logic signifi ca nce of these important g rowth peptides, and 
their specifi c receptors in human keratinocytes should lead to a 
better understanding of the regulation of epiderm al cell proli f-
eration . 
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